Accuracy and efficacy of tibiotalar joint injections under ultrasound guidance: A systematic review
Archives of ISPRM · 2026
DOI: 10.5606/archisprm.2026.31 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of ISPRM, 2026. Verfasst von Mahmood Gharib und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
In this systematic review, we assess the accuracy and effectiveness of ultrasound (US)-guided injections compared to alternative modalities for the treatment of tibiotalar joint. Materials and methods: A systematic review was conducted following the Cochrane process from April 2023 to August 2023 utilizing PubMed, Ovid Embase, Web of Science, and Scopus. Branched logic was used to include articles containing terms regarding the tibiotalar joint, US and injections. Studies were screened for eligibility by two authors, and any disagreements were resolved through discussion with a third reviewer. Risk of bias assessments were performed.
Results
A total of five studies were included in the review, comparing various local delivery techniques for the treatment of tibiotalar joint. Three of these studies were cadaveric, while two studies were performed in surviving patients. In general, both the cadaveric studies and studies in surviving patients demonstrated increased accuracy of US-guided compared to landmark (LM)-guided injections of the tibiotalar joint. In a randomized-controlled trial of US-guided versus LM-guided injections in patients with inflamed joints, there was a greater improvement in pain control according to Visual Analog Scale (VAS) scores at six weeks (30.6 mm vs. 21.2 mm; p = 0.030). A retrospective study demonstrated 2.3 times greater success with image-guidance (US or fluoroscopy) compared to LM, with no significant difference between US and fluoroscopy ( p = 0.09).
Conclusion
This systematic review provides evidence that US-guided injections demonstrate a higher level of accuracy as compared with LM-guided injections. However, risk of bias concerns, the limited number of included studies, particularly in vivo studies, and the lack of published, high-quality randomized-controlled trials investigating efficacy limit our ability to make definitive conclusions regarding clinical outcomes of US versus LM-guided tibiotalar injections.
Zitieren
APA
Gharib, M., Cleland, T., Peraka, V., Özçakar, L., & Jain, N. B. (2026). Accuracy and efficacy of tibiotalar joint injections under ultrasound guidance: A systematic review. Archives of ISPRM. https://doi.org/10.5606/archisprm.2026.31
Vancouver
Gharib M, Cleland T, Peraka V, Özçakar L, Jain NB. Accuracy and efficacy of tibiotalar joint injections under ultrasound guidance: A systematic review. Archives of ISPRM. 2026. doi:10.5606/archisprm.2026.31
BibTeX
@article{Gharib2026,
author = {Gharib, Mahmood and Cleland, Travis and Peraka, Veena and Özçakar, Levent and Jain, Nitin B.},
title = {Accuracy and efficacy of tibiotalar joint injections under ultrasound guidance: A systematic review},
journal = {Archives of ISPRM},
year = {2026},
doi = {10.5606/archisprm.2026.31}
}
EUVIMED